Variability in hormone and growth factor receptor expression in primary versus recurrent, metastatic, and post-neoadjuvant breast carcinoma.
about
Nanotechnology: Future of OncotherapyRecommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration.The prevalence of estrogen receptor-negative breast cancer in Ethiopia.Recent advances in the molecular characterization of circulating tumor cells.Modern therapies and iatrogenic changes in breast pathology.Plasma S100P level as a novel prognostic marker of metastatic breast cancer.
P2860
Variability in hormone and growth factor receptor expression in primary versus recurrent, metastatic, and post-neoadjuvant breast carcinoma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Variability in hormone and gro ...... -neoadjuvant breast carcinoma.
@en
type
label
Variability in hormone and gro ...... -neoadjuvant breast carcinoma.
@en
prefLabel
Variability in hormone and gro ...... -neoadjuvant breast carcinoma.
@en
P2093
P2860
P1476
Variability in hormone and gro ...... -neoadjuvant breast carcinoma.
@en
P2093
Cleo Y Massad
Fouad I Boulos
Mark N Jabbour
P2860
P2888
P356
10.1007/S10549-012-2047-Z
P407
P577
2012-04-08T00:00:00Z
P6179
1019112004